| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 107.238 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 94.6233 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 74.7243 | 70 |
| GSM780719 | Untreated after 4 days (C1_2) | 119.655 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 95.5562 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 82.8181 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 143.874 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 100.601 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 315.603 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 153.925 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 99.6816 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 344.527 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 73.8605 | 70 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 139.986 | 80 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 135.392 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 98.3441 | 75 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 131.608 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 141.466 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 75.5383 | 71 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 96.5846 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 108.011 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 84.1511 | 73 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 92.4912 | 74 |